Cleared Traditional

K172453 - WATCHDOG Hemostasis Valve Kit

K172453 is an FDA 510(k) clearance for WATCHDOG Hemostasis Valve Kit, manufactured by Boston Scientific Corporation. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Traditional 510(k) pathway after a 87-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2017
Decision
87d
Days
Class 2
Risk

K172453 is an FDA 510(k) clearance for the WATCHDOG Hemostasis Valve Kit. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Boston Scientific Corporation (Maple Grove, US). The FDA issued a Cleared decision on November 9, 2017 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boston Scientific Corporation devices

FDA 510(k) Submission Details - K172453

510(k) Number K172453 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 14, 2017
Decision Date November 09, 2017
Days to Decision 87 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 125d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 685
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K172453.
Lunderquist Extra Stiff Wire Guide
K171513 · William Cook Europe Aps · Dec 2017
TXM Hydrophilic Guidewire
K170915 · Texasmedical Technologies, Inc. · Nov 2017
MR Wire Guide Wire Straight, MR Wire Guide Wire Angled
K173423 · Nano4imaging GmbH · Nov 2017
Heraeus TMW Guidewire
K173052 · Heraeus Medical Components, LLC · Oct 2017
Glidewire GT
K170417 · Terumo Corporation · Sep 2017
Hi-Torque Command 18 Guide Wire
K172073 · Abbott Vascular · Aug 2017